Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Establishment Labs Holdings Inc (ESTA)

Establishment Labs Holdings Inc (ESTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Establishment Labs Reports First Quarter 2026 Financial Results Business Wire - Wed May 6, 7:00AM CDT

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced...

ESTA : 74.54 (+5.00%)
Establishment Labs' Profitability Path May Already Be Priced In Barchart - Tue May 5, 4:13PM CDT

Barchart Research What to Expect from ESTA Earnings ESTA Generated May 5, 2026 Current Price $70.98 EPS Estimate $$-0.28 Consensus Rating Strong Buy Average Move 7.11% Establishment Labs' Profitability...

ESTA : 74.54 (+5.00%)
Establishment Labs® Refinances Credit Facility Business Wire - Thu Apr 30, 7:53AM CDT

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today...

ESTA : 74.54 (+5.00%)
Establishment Labs® to Announce First Quarter 2026 Financial Results on May 6 Business Wire - Thu Apr 23, 7:00AM CDT

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, plans to...

ESTA : 74.54 (+5.00%)
Establishment Labs® Surpasses More Than Five Million Motiva® Devices in Market Business Wire - Tue Apr 7, 7:00AM CDT

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today...

ESTA : 74.54 (+5.00%)
Establishment Labs Announces Leadership Transition to Support Next Phase of Growth Business Wire - Tue Feb 24, 7:00AM CST

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced...

GCO : 34.64 (+0.41%)
ESTA : 74.54 (+5.00%)
Establishment Labs Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Guidance Business Wire - Tue Feb 24, 7:00AM CST

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced...

ESTA : 74.54 (+5.00%)
Establishment Labs to Present at TD Cowen's 46th Annual Health Care Conference Business Wire - Wed Feb 18, 7:00AM CST

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced...

ESTA : 74.54 (+5.00%)
Establishment Labs to Announce Fourth Quarter 2025 Financial Results on February 24 Business Wire - Tue Feb 10, 7:00AM CST

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, plans to...

ESTA : 74.54 (+5.00%)
Establishment Labs Announces Preliminary Unaudited Financial Results for Fourth Quarter and Fiscal Year 2025 Business Wire - Mon Jan 12, 7:00AM CST

Revenue for the quarter ended December 31, 2025 is expected to be between $64.0 million and $65.0 million, including between $17.0 million and $17.5 million from Motiva sales in the United States. ...

ESTA : 74.54 (+5.00%)

Barchart Exclusives

Time to Buy: This Cheap High-Yield Dividend Stock Is Trading Near Multi-Year Lows Barchart - Wed May 6, 6:30PM CDT
Accenture's dividend yield is now over 3.6% thanks to the decline in its stock price. The stock's valuations have started to appear tempting at these levels, even though there are lingering concerns over AI being a risk to the company's business. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.